Registration Dossier
Registration Dossier
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 202-476-7 | CAS number: 96-09-3
Endpoint summary
Administrative data
Description of key information
Acute toxicity data for styrene oxide are available for the oral, dermal and inhalation route.
Key value for chemical safety assessment
Acute toxicity: via oral route
Endpoint conclusion
- Dose descriptor:
- LD50
- Value:
- 4 290 mg/kg bw
Acute toxicity: via inhalation route
Endpoint conclusion
- Dose descriptor:
- LC50
- Value:
- 2 450 mg/m³ air
Acute toxicity: via dermal route
Endpoint conclusion
- Dose descriptor:
- LD50
- Value:
- 1 060 mg/kg bw
Additional information
In an acute oral toxicity study, groups of 5 nonfasted, Carworth-Wistar rats weighing 90 to 120 g were given a single oral dose of styrene oxide at doses not reported in detail and observed for 14 days.Theoral LD50is 4290 mg/kg bw (95% C.I. 3070 - 5980).
In an acute dermal toxicity study, using the one-day cutt method of Draize, groups of four male New Zealand giant albino rabbits were exposed to the closely clipped fur to 1/10 of the body surface. The dose retained beneath an impervious plaster film for 24 hours. Mortality was considered complete after additional 14 days. The dermal LD50was determined to be 1060 mg/kg bw(95% C.I. 630 - 1790).
In an acute inhalation toxicity study, groups of 6 young adult male Carworth-Wistar rats were exposed by inhalation route to vapours of styrene oxide for 4 hours at concentrations of 500 ppm. Animals then were observed for 14 days. At a concentration of 500 ppm 2 of 6 animals died. The inhalatory LC50was determined to be 500 ppm, corresponding to 2.45 mg/L (2450 mg/m³) for 4 hours.
Findings with respect to specific target organ toxicity are not reported in neither of the publications.
Justification for classification or non-classification
Based on the results the following classification of styrene oxide according to Directive 67/548/EEC and GHS Regulation EC No 1272/2008 with respect to acute toxicity is required.
Acute toxicity route |
Value |
Directive 67/548/EEC |
GHS Regulation EC No 1272/2008 |
Oral |
LD50 4290 mg/kg bw |
no classification |
no classification |
Dermal* |
LD50 1060 mg/kg bw |
Xn; R 21 |
Cat. IV |
inhalation |
LC50500 ppm vapour (2.45 mg/L) |
Xn; R 20 |
Cat. III |
* For the dermal route styrene oxide is subject to legal binding classification
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
